ITEM VIEW

Retrospective analysis of radiotherapy outcomes in breast cancer radiotherapy at a single institution

dc.contributor.authorHeunis, M.en_ZA
dc.contributor.authorLombe, D. C.en_ZA
dc.contributor.authorMcCaulb, M.en_ZA
dc.date.accessioned2020-02-10T09:27:01Z
dc.date.available2020-02-10T09:27:01Z
dc.date.issued2018
dc.identifier.citationHeunis, M., Lombe, D. C. & McCaulb, M. 2018. Retrospective analysis of radiotherapy outcomes in breast cancer radiotherapy at a single institution. Southern African Journal of Gynaecological Oncology, 10(1):1-4, doi:10.1080/20742835.2018.1429521
dc.identifier.issn2220-105X (online)
dc.identifier.issn2074-2835 (print)
dc.identifier.otherdoi:10.1080/20742835.2018.1429521
dc.identifier.urihttp://hdl.handle.net/10019.1/107459
dc.descriptionCITATION: Heunis, M., Lombe, D. C. & McCaulb, M. 2018. Retrospective analysis of radiotherapy outcomes in breast cancer radiotherapy at a single institution. Southern African Journal of Gynaecological Oncology, 10(1):1-4, doi:10.1080/20742835.2018.1429521.
dc.descriptionThe original publication is available at https://www.tandfonline.com
dc.description.abstractIntroduction: Breast cancer is the most commonly diagnosed cancer worldwide. With the challenges of cancer treatment in developing countries there is a need for a systematic and methodical approach to treatment in resource-limited settings. Objective: To retrospectively evaluate the profile of breast cancer patients irradiated with curative intent and discuss the therapeutic outcomes, and to compare this cohort with the available developed-world data. Methods: A retrospective cohort of 689 breast cancer patients from 2010–2014 at Tygerberg Hospital, Western Cape Province was analysed. The best-case disease-free survival was calculated at five years and compared with the SEER database. Various prognostic factors were calculated by univariate and multivariate analysis. Results: The five-year best-case disease-free survival (DFS) for Stage I is 94.7% (95% CI 68–99) and for Stage IIIC, 71.3% (95% CI 39–88). Conclusion: Outcomes of treatment at this institution are comparable to data reported in first-world countries. As twodimensional radiotherapy compares with most Cobalt specifications, the majority of breast cancer patients in sub-Saharan Africa can be treated efficiently with Cobalt-type technology.en_ZA
dc.description.urihttps://www.tandfonline.com/doi/full/10.1080/20742835.2018.1429521
dc.format.extent4 pages
dc.language.isoen_ZAen_ZA
dc.publisherMedpharm Publications
dc.subjectBreast canceren_ZA
dc.titleRetrospective analysis of radiotherapy outcomes in breast cancer radiotherapy at a single institutionen_ZA
dc.typeArticleen_ZA
dc.description.versionPublisher's version
dc.rights.holderAuthors retain copyright


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW